InvestorsHub Logo
Followers 14
Posts 3809
Boards Moderated 1
Alias Born 07/07/2002

Re: None

Friday, 05/09/2014 2:20:46 PM

Friday, May 09, 2014 2:20:46 PM

Post# of 195
There is no way Hansen can grab any market share in existing markets. Corpath is way cheaper and penetrating the PCI market quickly. Stereotaxis is already there for 90% of the EP robotic procedures. Now they are talking about going to thicker 10F sheaths for the Magellan PCI system. It is like throwing wet toilet paper to see what sticks. And they are running of money quickly. 10Q will include "going concern" statement as a result. Massive dilution coming up.